authors
- Wang, Haichen
- Dingledine, Raymond J
- Myers, Scott J
- Traynelis, Stephen F
- Fang, Chuan
- Tan, Yanli
- Koszalka, George W
- Daniel Laskowitz, MD, MHS
Clinical development of the GluN2B-selective NMDA receptor inhibitor NP10679 for the treatment of neurologic deficit after subarachnoid hemorrhage.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- November 26, 2024